Neuroserpin: a serpin to think about

被引:105
作者
Miranda, E [1 ]
Lomas, DA [1 ]
机构
[1] Univ Cambridge, Cambrige Inst Med Res, Dept Med, Cambridge CB2 2XY, England
基金
英国医学研究理事会;
关键词
serpin; tissue-type plasminogen activator (tPA); proteinases; proteinase inhibitors; nervous system; polymers; FENIB; serpinopathies; conformational disease;
D O I
10.1007/s00018-005-5077-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteinases and their inhibitors play important roles in neural development, homeostasis and disease. Neuroserpin is a member of the serine proteinase inhibitor (serpin) superfamily that is secreted from the growth cones of neurons and inhibits the enzyme tissue-type plasminogen activator (tPA). The temporal and spatial pattern of neuroserpin expression suggests a role in synaptogenesis and is most prominent in areas of the brain that participate in learning, memory and behaviour. Neuroserpin also provides neuronal protection in pathologies such as cerebral ischaemia and epilepsy by preventing excessive activity of tPA. Point mutations in neuroserpin cause aberrant conformational transitions and the formation of loop-sheet polymers that are retained within the endoplasmic reticulum of neurons, forming inclusion bodies that underlie an autosomal dominant dementia that we have called familial encephalopathy with neuroserpin inclusion bodies or FENIB. We review here the role of neuroserpin and other proteinase inhibitors in brain development, function and disease.
引用
收藏
页码:709 / 722
页数:14
相关论文
共 171 条
[1]   EXPRESSION OF CATHEPSIN G-LIKE AND ALPHA(1)-ANTICHYMOTRYPSIN-LIKE PROTEINS IN REACTIVE ASTROCYTES [J].
ABRAHAM, CR ;
KANEMARU, K ;
MUCKE, L .
BRAIN RESEARCH, 1993, 621 (02) :222-232
[2]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[3]  
Abraham CR, 2000, ANN NY ACAD SCI, V920, P245
[4]   THE PROTEASE INHIBITOR, ALPHA-1-ANTICHYMOTRYPSIN, IS A COMPONENT OF THE BRAIN AMYLOID DEPOSITS IN NORMAL AGING AND ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
POTTER, H .
ANNALS OF MEDICINE, 1989, 21 (02) :77-81
[5]   Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease [J].
Akenami, FOT ;
Koskiniemi, M ;
Farkkila, M ;
Vaheri, A .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (02) :157-160
[6]   THROMBIN ACCUMULATION IN BRAINS OF PATIENTS WITH ALZHEIMERS-DISEASE [J].
AKIYAMA, H ;
IKEDA, K ;
KONDO, H ;
MCGEER, PL .
NEUROSCIENCE LETTERS, 1992, 146 (02) :152-154
[7]   Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro [J].
Barker-Carlson, K ;
Lawrence, DA ;
Schwartz, BS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :46852-46857
[8]   Plasminogen expression in the neonatal and adult mouse brain [J].
Basham, ME ;
Seeds, NW .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (01) :318-325
[9]   Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers - Implications for the epilepsy seen in the dementia FENIB [J].
Belorgey, D ;
Sharp, LK ;
Crowther, DC ;
Onda, M ;
Johansson, J ;
Lomas, DA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (16) :3360-3367
[10]   Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro [J].
Belorgey, D ;
Crowther, DC ;
Mahadeva, R ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17367-17373